Exosomes combined with biomaterials in the treatment of spinal cord injury
Open accessThe DOI matches its Crossref record; 121 of the 121 references it cites were found in a registry or an index.
Abstract
Spinal cord injury (SCI) is a serious and disabling disease with a high mortality rate. It often leads to complete or partial sensory and motor dysfunction and is accompanied by a series of secondary outcomes, such as pressure sores, pulmonary infections, deep vein thrombosis in the lower extremities, urinary tract infections, and autonomic dysfunction. Currently, the main treatments for SCI include surgical decompression, drug therapy, and postoperative rehabilitation. Studies have shown that cell therapy plays a beneficial role in the treatment of SCI. Nonetheless, there is controversy regarding the therapeutic effect of cell transplantation in SCI models. Meanwhile exosomes, as a new therapeutic medium for regenerative medicine, possess the advantages of small size, low immunogenicity, and the ability to cross the blood-spinal cord barrier. Certain studies have shown that stem cell-derived exosomes have anti-inflammatory effects and can play an irreplaceable role in the treatment of SCI. In this case, it is difficult for a single treatment method to play an effective role in the repair of neural tissue after SCI. The combination of biomaterial scaffolds and exosomes can better transfer and fix exosomes to the injury site and improve their survival rate. This paper first reviews the current research status of stem cell-derived exosomes and biomaterial scaffolds in the treatment of SCI respectively, and then describes the application of exosomes combined with biomaterial scaffolds in the treatment of SCI, as well as the challenges and prospects.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures


Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“EVs have gained significant attention in CNS injuries, specifically traumatic brain injuries (TBI) and spinal cord injuries (SCI), due to their intricate involvement in injury response, repair processes, and their potential applications as therapeutic agents and biomarkers [175–177].”
From Extracellular vesicles as nanotheranostic platforms for targeted neurological disorder interventions (2024) · cites this paper as [176]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The third dimension bridges the gap between cell culture and live tissue
Pampaloni, F., Reynaud, E. G., & Stelzer, E. H. K. (2007) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2236 · Cited by 2,817
Designing Cell-Compatible Hydrogels for Biomedical Applications
Seliktar, D. (2012) · Science · doi:10.1126/science.1214804 · Cited by 1,923 · cited 1×
“There are four main properties for biomedical applications: degradability, adhesion, bioactivity, and mechanical properties (Seliktar, 2012).”
BackgroundFunctional delivery of viral miRNAs via exosomes
Pegtel, D. M., Cosmopoulos, K., Thorley-Lawson, D. A., van Eijndhoven, M. A. J., Hopmans, E. S., Lindenberg, J. L., de Gruijl, T. D., Würdinger, T., & Middeldorp, J. M. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0914843107 · Cited by 1,641 · cited 1×
“Exosomes have emerged as a promising vehicle for miRNA delivery to the central nervous system (Pegtel et al., 2010; Sancho-Albero et al., 2019).”
BackgroundBioinks for 3D bioprinting: an overview
Gungor-Ozkerim, P. S., Inci, I., Zhang, Y. S., Khademhosseini, A., & Dokmeci, M. R. (2018) · Biomaterials Science · doi:10.1039/c7bm00765e · Cited by 1,428
Spinal Cord Injury: Pathophysiology, Multimolecular Interactions, and Underlying Recovery Mechanisms
Anjum, A., Yazid, M. D., Fauzi Daud, M., Idris, J., Ng, A. M. H., Selvi Naicker, A., Ismail, O. H. R., Athi Kumar, R. K., & Lokanathan, Y. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21207533 · Cited by 1,270 · cited 1×
“Secondary injury is a pathological process caused after the primary injury that includes continuous hemorrhage, neuroinflammation, oxidative stress, and edema leading to massive necrosis, which in turn trigger free radical formation, glutamate-mediated excitotoxicity, and neurotoxicity (Anjum et al., 2020).”
BackgroundExosome Theranostics: Biology and Translational Medicine
He, C., Zheng, S., Luo, Y., & Wang, B. (2018) · Theranostics · doi:10.7150/thno.21945 · Cited by 1,249 · cited 1×
“Exosomes are vesicles that are continuously released by cells to the extracellular environment, with a diameter of about 40–100 nm, and contain a variety of biomolecules such as lipids, proteins and nucleic acids (He et al., 2018).”
BackgroundExtracellular matrix-based materials for regenerative medicine
Hussey, G. S., Dziki, J. L., & Badylak, S. F. (2018) · Nature Reviews Materials · doi:10.1038/s41578-018-0023-x · Cited by 844 · cited 1×
“The extracellular matrix contains intrinsic biochemical and mechanical signals that play an irreplaceable role in regulating the phenotype and function of cell development, homeostasis, and response to injury (Hussey et al., 2018).”
BackgroundBiomimetic 3D-printed scaffolds for spinal cord injury repair
Koffler, J., Zhu, W., Qu, X., Platoshyn, O., Dulin, J. N., Brock, J., Graham, L., Lu, P., Sakamoto, J., Marsala, M., et al. (2019) · Nature Medicine · doi:10.1038/s41591-018-0296-z · Cited by 708 · cited 1×
“3D bioprinting technology has been applied to a variety of tissues including bone, cartilage, vascular systems, muscle and heart, but there are relatively few studies regarding SCI (Koffler et al., 2019; Sun et al., 2019; Hou et al., 2022).”
BackgroundLiu, W., Rong, Y., Wang, J., Zhou, Z., Ge, X., Ji, C., Jiang, D., Gong, F., Li, L., Chen, J., et al. (2020) · Journal of Neuroinflammation · doi:10.1186/s12974-020-1726-7 · Cited by 573 · cited 1×
“Recent studies suggest that the role of MSCs in the treatment of SCI is attributed to their paracrine mechanism and that exosomes may play an important role in this process (Lee et al., 2020; Liu et al., 2020).”
BackgroundSpinal cord repair: advances in biology and technology
Courtine, G., & Sofroniew, M. V. (2019) · Nature Medicine · doi:10.1038/s41591-019-0475-6 · Cited by 508 · cited 1×
“Biomaterials have promising applications in enhancing spinal cord injury repair (Courtine and Sofroniew, 2019).”
Background
Cited by
Role of Stem Cell-Derived Exosomes and microRNAs in Spinal Cord Injury
Hwang, J., Jang, S., Kim, C., Lee, S., & Jeong, H. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241813849 · Cited by 37
“They also have a neuroprotective, angiogenic, and immunomodulatory effect and easily cross the blood–spinal-cord barrier to promote axonal regeneration [19,76].”
BackgroundDecellularized extracellular matrix in the treatment of spinal cord injury
Jiang, W., Zhang, X., Yu, S., Yan, F., Chen, J., Liu, J., & Dong, C. (2023) · Experimental Neurology · doi:10.1016/j.expneurol.2023.114506 · Cited by 31
Self-citationLi, L., Wang, Y., Xu, Y., Xu, J., Zhao, Y., Cheng, Z., Fang, Y., Miao, Y., & Zhang, X. (2024) · Journal of Controlled Release · doi:10.1016/j.jconrel.2024.05.048 · Cited by 29
Self-citationWang, G., Li, Q., Liu, S., Mo, L., Liu, B., Zhao, T., Liu, B., & Chen, Z. (2024) · Materials Today Bio · doi:10.1016/j.mtbio.2024.101250 · Cited by 42
“…hyaluronic acid, gelatin, alginate, and extracellular matrix (ECM) are widely recognized for their three-dimensional structure, injectability, biode-gradability, and excellent compatibility with cells, making them extensively used in drug and cell delivery for regenerative medicine [14 – 16].”
BackgroundExtracellular vesicles as nanotheranostic platforms for targeted neurological disorder interventions
Choi, H. K., Chen, M., Goldston, L. L., & Lee, K.-B. (2024) · Nano Convergence · doi:10.1186/s40580-024-00426-5 · Cited by 26
Metadata
- Authors
- Zhang, X., Jiang, W., Lu, Y., Mao, T., Gu, Y., Ju, D., & Dong, C.
- Affiliations
- Nantong University (CN)
- Corresponding author
- Dong, Chuanming
- Venue
- Frontiers in Bioengineering and Biotechnology
- Publisher
- Frontiers Media SA
- Published
- 2023-03-13
- Volume
- 11
- Pages
- 1077825-1077825
- ISSN
- 2296-4185 (ISSN-L)
- PMC
- PMC10040754
- OpenAlex
- W4324088316
- Cited by
- 32
- References
- 121
- Citations by year
- 2026: 7 · 2025: 10 · 2024: 9 · 2023: 6
- FWCI
- 1.45
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Frontiers in Bioengineering and Biotechnology (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- National Natural Science Foundation of China (82171380)
- Government of Jiangsu Province
- Topics
- Health Sciences › Medicine › Clinical Neurology › Spinal Cord Injury Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Extracellular vesicles in disease
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Nerve injury and regeneration
- Keywords
- spinal cord injury, exosomes, stem cell-derived exosomes, biomaterial scaffolds, exosome delivery, neural repair, anti-inflammatory activity, cell therapy, regenerative medicine, blood-spinal cord barrier
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Exosomes combined with biomaterials in the treatment of spinal cord injury. https://app.cochat.ai/papers/10.3389/fbioe.2023.1077825
- The paper
- Zhang, X., Jiang, W., Lu, Y., Mao, T., Gu, Y., Ju, D., & Dong, C. (2023). Exosomes combined with biomaterials in the treatment of spinal cord injury. Frontiers in Bioengineering and Biotechnology. https://doi.org/10.3389/fbioe.2023.1077825
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.